Receptor for advanced glycation end products (RAGE) serves a protective role during Klebsiella pneumoniae-induced pneumonia

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Achouiti, Ahmed ^a   De Vos, Alex F ^a   Van'T Veer, Cornelis ^a   Florquin, Sandrine ^a   Tanck, Michael W ^a   Nawroth, Peter P ^b   Bierhaus, Angelika ^b   Van Der Poll, Tom ^a   Van Zoelen, Marieke A D ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LONG ISLAND UNIVERSITY   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; CHEMOKINE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CELL PHAGOCYTOSIS; CONTROLLED STUDY; CYTOKINE RELEASE; GRANULOCYTE; IMMUNE RESPONSE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETHALITY; LIVER CELL DAMAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SURVIVAL; WILD TYPE MOUSE; ANIMAL; GENETICS; KLEBSIELLA INFECTION; KNOCKOUT MOUSE; LUNG; METABOLISM;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; CHEMOKINES; CYTOKINES; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MICE; MICE, KNOCKOUT;

EID: 84958576704     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141000     Document Type: Article

References (50)

1. Kollef MH, Kollef KE (2005) Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. Chest 128: 2706-2713. PMID: 16236946
2. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11: 589-603. PMID: 9767057
3. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, et al. (2011) Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 62: 26-33. doi: 10.1016/j.jinf.2010.10.010 PMID: 21056057
4. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH (2006) Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med 34: 2588-2595. PMID: 16915117
5. Giamarellou H (2005) Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 11 Suppl 4: 1-16. PMID: 15953019
6. Christaki E, Lazaridis N, Opal SM (2012) Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis? Curr Opin Infect Dis 25: 304-311. PMID: 22327468
7. van Zoelen MA, Achouiti A, van der Poll T (2011) The role of receptor for advanced glycation endproducts (RAGE) in infection. Crit Care 15: 208. doi: 10.1186/cc9990 PMID: 21457506
8. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
9. Huttunen HJ, Fages C, Rauvala H (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274: 19919-19924. PMID: 10391939
10. Liu R, Mori S, Wake H, Zhang J, Liu K, Izushi Y, et al. (2009) Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation endproducts: heparin's effect on binding. Acta Med Okayama 63: 203-211. PMID: 19727205
11. Srikrishna G, Nayak J, Weigle B, Temme A, Foell D, Hazelwood L, et al. (2010) Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J Cell Biochem 110: 645-659. doi: 10.1002/jcb.22575 PMID: 20512925
12. Xie J, Burz DS, He W, Bronstein IB, Lednev I, Shekhtman A (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 282: 4218-4231. PMID: 17158877
13. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-51. PMID: 10398600
14. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ, et al. (2005) Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 33: 564-573. PMID: 15753748
15. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, et al. (2004) Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170: 1310-1316. PMID: 15374839
16. van Zoelen MA, Laterre PF, van Veen SQ, van Till JW, Wittebole X, Bresser P, et al. (2007) Systemic and local high mobility group box 1 concentrations during severe infection. Crit Care Med 35: 2799-2804. PMID: 17901841
17. Foell DMD, Wittkowski H, Kessel C, Luken A, Weinhage T, Varga G, et el. (2013) Pro-inflammatory S100A12 can Activate Human Monocytes via Toll-like Receptor 4. Am J Respir Crit Care Med.
18. van Zoelen MA, Achouiti A, Schmidt AM, Yang H, Florquin S, Tracey KJ, et al. (2010) Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis. Crit Care Med.
19. Chavakis T, Bierhaus A, Al Fakhri N, Schneider D, Witte S, Linn T, et al. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198: 1507-1515. PMID: 14623906
20. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-1650. PMID: 15173891
21. Lutterloh EC, Opal SM, Pittman DD, Keith JC Jr, Tan XY, Clancy BM, et al. (2007) Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care 11: R122. PMID: 18042296
22. van Zoelen MA, Schmidt AM, Florquin S, Meijers JC, de Beer R, de Vos AF, et al. (2009) Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J Infect Dis 200: 765-773. doi: 10.1086/604730 PMID: 19627249
23. van Zoelen MA, Schouten M, de Vos AF, Florquin S, Meijers JC, Nawroth PP, et al. (2009) The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 182: 4349-4356. doi: 10.4049/jimmunol.0801199 PMID: 19299735
24. Christaki E, Opal SM, Keith JC Jr, Kessimian N, Palardy JE, Parejo NA, et al. (2011) A Monoclonal Antibody Against RAGE Alters Gene Expression and is Protective in Experimental Models of Sepsis and Pneumococcal Pneumonia. Shock 35: 492-498. PMID: 21263385
25. Bartlett JG, Mundy LM (1995) Community-acquired pneumonia. N Engl J Med 333: 1618-1624. PMID: 7477199
26. Brown PD, Lerner SA (1998) Community-acquired pneumonia. Lancet 352: 1295-1302. PMID: 9788476
27. Constien R, Forde A, Liliensiek B, Grone HJ, Nawroth P, Hammerling G, et al. (2001) Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 30: 36-44. PMID: 11353516
28. Renckens R, Roelofs JJ, Bonta PI, Florquin S, de Vries CJ, Levi M, et al. (2007) Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 109: 1593-1601. PMID: 17032919
29. van der Windt GJ, Hoogerwerf JJ, de Vos AF, Florquin S, van der Poll T (2010) Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J.
30. Wiersinga WJ, Wieland CW, Roelofs JJ, van der Poll T (2008) MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One 3: e3494. doi: 10.1371/journal.pone.0003494 PMID: 18946505
31. Cheng C, Tsuneyama K, Kominami R, Shinohara H, Sakurai S, Yonekura H, et al. (2005) Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol 18: 1385-1396. PMID: 15933755
32. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M (2006) The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol 19: 1437-1445. PMID: 16941014
33. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, et al. (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173: 1008-1015. PMID: 16456142
34. Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, van der Poll T, Hoidal JR, et al. (2007) Neutrophil- derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 35: 1369-1375. PMID: 17414728
35. Sorci G, Riuzzi F, Arcuri C, Giambanco I, Donato R (2004) Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol Cell Biol 24: 4880-4894. PMID: 15143181
36. van Zoelen MA, Ishizaka A, Wolthuls EK, Choi G, van der Poll T, Schultz MJ (2008) Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 29: 441-445. PMID: 18344842
37. van Zoelen MA, van der Sluijs KF, Achouiti A, Florquin S, Braun-Pater JM, Yang H, et al. (2009) Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia. Virology 391: 265-273. doi: 10.1016/j.virol.2009.05.032 PMID: 19592063
38. Knapp S, Schultz MJ, van der Poll T (2005) Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock 24 Suppl 1: 12-18. PMID: 16374367
39. Strieter RM, Belperio JA, Keane MP (2003) Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 16: 193-198. PMID: 12821807
40. Rijneveld AW, Weijer S, Florquin S, Esmon CT, Meijers JC, Speelman P, et al. (2004) Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 103: 1702-1709. PMID: 14592828
41. Leemans JC, Vervoordeldonk MJ, Florquin S, van Kessel KP, van der Poll T (2002) Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med 165: 1445-1450. PMID: 12016110
42. Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, et al. (2008) Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the plateletactivating factor receptor. J Immunol 180: 3478-3484. PMID: 18292574
43. Ramsgaard L, Englert JM, Manni ML, Milutinovic PS, Gefter J, Tobolewski J, et al. (2011) Lack of the Receptor for Advanced Glycation End-Products Attenuates E. coli Pneumonia in Mice. PLoS One 6: e20132. doi: 10.1371/journal.pone.0020132 PMID: 21629785
44. Fuellen G, Foell D, Nacken W, Sorg C, Kerkhoff C (2003) Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction. Trends Immunol 24: 622-624. PMID: 14644132
45. Yamamoto Y, Harashima A, Saito H, Tsuneyama K, Munesue S, Motoyoshi S, et al. (2011) Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol 186: 3248-3257. doi: 10.4049/jimmunol.1002253 PMID: 21270403
46. Haslett C (1999) Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J Respir Crit Care Med 160: S5-11. PMID: 10556161
47. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, et al. (2003) Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 167: 171-179. PMID: 12406830
48. Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A, et al. (2011) Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol 186: 6191-6198. doi: 10.4049/jimmunol.1004134 PMID: 21502377
49. Strieter RM, Belperio JA, Keane MP (2002) Cytokines in innate host defense in the lung. J Clin Invest 109: 699-705. PMID: 11901175
50. Zen K, Chen CX, Chen YT, Wilton R, Liu Y (2007) Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 178: 2483-2490. PMID: 17277156